{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:23:23Z","timestamp":1758043403733,"version":"3.44.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Chronic kidney disease (CKD) has a high prevalence, poor prognosis, and high medical costs, and awareness of the disease is low. Therefore, in this study, we aimed to simulate and analyze the evolution of CKD burden among different groups at high risk of CKD in Shanghai, with or without screening intervention, and provide a quantifiable basis for the selection of screening intervention strategies for CKD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A micro-simulation model was constructed to analyze the evolution of CKD burden using data from CKD screening of the population in the Jing\u2019an and Minhang Districts of Shanghai, China, from January 2015 to December 2020. SAS Statistical Software 9.4 was used to simulate and analyze the evolution of disease burden under different screening intervention strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>By 2033, screening interventions for high-risk groups with hypertension, diabetes, and an age of 65\u202fyears and older would be associated with 6,250 fewer patients with end-stage renal disease. Furthermore, the number of patients with end-stage renal disease would be reduced to only 41.64% of the projected number of patients without screening intervention, leading to a general improvement in the quality of life of the population, better quality-adjusted life-years, and a reduction in the economic burden of disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The results of this study highlight the importance of combining the concepts of integrated prevention and treatment of chronic diseases to improve screening and intervention of CKD for people with hypertension, diabetes, and those aged 65\u202fyears and older, thereby effectively reducing the number of patients with end-stage renal disease, lowering the cost of treatment and intervention, and improving the quality of life of the population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2025.1608445","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:38:12Z","timestamp":1757655492000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating disease burden in chronic kidney disease screening using a micro-simulation model"],"prefix":"10.3389","volume":"13","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangfeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2369-13-10","article-title":"What do we know about chronic kidney disease in India: first report of the Indian CKD registry","volume":"13","author":"Rajapurkar","year":"2012","journal-title":"BMC Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10157-009-0199-x","article-title":"Prevalence of chronic kidney disease in the Japanese general population","volume":"13","author":"Imai","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1681\/ASN.2015050542","article-title":"CKD prevalence varies across the European general population","volume":"27","author":"Bruck","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/jech-2015-205834","article-title":"Chronic kidney disease among adult participants of the ELSA-Brasil cohort: association with race and socioeconomic position","volume":"70","author":"Barreto","year":"2016","journal-title":"J Epidemiol Community Health"},{"key":"ref5","volume-title":"2016 USRDS annual data report: Epidemiology of kidney disease in the United States","year":"2016"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S2214-109X(16)00071-1","article-title":"Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study","volume":"4","author":"Ene-Iordache","year":"2016","journal-title":"Lancet Glob Health"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/ki.2011.368","article-title":"The contribution of chronic kidney disease to the global burden of major noncommunicable diseases","volume":"80","author":"Couser","year":"2011","journal-title":"Kidney Int"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","article-title":"Prevalence of chronic kidney disease in China: a cross-sectional survey","volume":"379","author":"Zhang","year":"2012","journal-title":"Lancet"},{"key":"ref10","volume-title":"Analysis of the prevalence and influencing factors of chronic kidney disease in Shanghai","author":"Chanjuan","year":"2019"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3760\/cma.j.issn.1001-7097.2020.01.001","article-title":"Community screening analysis of high-risk groups of chronic kidney disease in Jing'an district of Shanghai","volume":"12","author":"Zhao","year":"2020","journal-title":"Chin J Nephrol"},{"key":"ref12","year":"2018"},{"key":"ref13","volume-title":"A Brief Discussion on Prevention and Treatment of Uremia","year":"2018"},{"key":"ref14","volume-title":"Empirical study on integrated prevention and treatment of stroke","author":"Chunlin","year":"2021"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"A86","DOI":"10.5334\/ijic.3198","article-title":"The future of chronic conditions management in NSW: integrated care for people with chronic conditions","volume":"17","author":"Lilley","year":"2017","journal-title":"Int J Integr Care"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/hex.12391","article-title":"Development and psychometric evaluation of a measure to evaluate the quality of integrated care: the patient assessment of integrated elderly care","volume":"19","author":"Uittenbroek","year":"2016","journal-title":"Health Expect"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/jep.13605","article-title":"Healthcare stakeholders' perspective on barriers to integrated care in Switzerland: results from the open-ended question of a nationwide survey","volume":"28","author":"Rawlinson","year":"2022","journal-title":"J Eval Clin Pract"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.16781\/j.0258-879x.2018.01.0024","article-title":"Advantages and significance of a three-level prevention and treatment system for chronic kidney disease in Shanghai","volume":"39","author":"Wang","year":"2018","journal-title":"Acad J Second Mil Med"},{"key":"ref19","year":"2018"},{"key":"ref20","year":""},{"key":"ref21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3969\/j.issn.1006-298X.2021.01.017","article-title":"Introduction to the core units of the National Chronic Kidney Disease Management Center (CKDMC)","volume":"30","author":"Xia","year":"2021","journal-title":"Chin J Nephrol Dial Transplant"},{"key":"ref22","volume-title":"Shanghai Statistical Yearbook 2021","year":"2021"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6962654","article-title":"ACEI and ARB lower the incidence of end-stage renal disease among patients with diabetic nephropathy: a meta-analysis","author":"Deng","year":"2022","journal-title":"Comput. Math. Methods. Med."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/pds.3941","article-title":"The effect of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies","volume":"25","author":"Qin","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1608445\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:38:16Z","timestamp":1757655496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1608445\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":25,"alternative-id":["10.3389\/fpubh.2025.1608445"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1608445","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"article-number":"1608445"}}